Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Nutr ; 30(5): 578-84, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21474219

ABSTRACT

BACKGROUND & AIMS: To assess the effect of an enteral diet enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and anti-oxidants on the incidence of organ dysfunction and nosocomial infections in septic patients with acute lung injury or acute respiratory distress syndrome (ARDS) compared with a standard enteral diet. METHODS: This prospective, randomized, open-label study was performed in 11 Spanish intensive care units (ICU). Adult patients with sepsis and acute lung injury or ARDS were randomly allocated to receive either an EPA-GLA diet or a control diet. RESULTS: Of the 198 patients that were eligible, 160 were randomized and 132 were studied. Patient demographics, APACHE II and SOFA scores, and nutritional variables on admission were similar between the EPA-GLA diet and control diet groups. The EPA-GLA diet group showed a trend toward a decreased SOFA score, but it was not significant. No differences were observed in the PaO(2)/FiO(2) ratio or the days on mechanical ventilation between the groups. Incidence of infections was similar in the groups. The control group stayed longer in the ICU than the EPA-GLA diet group (16 vs. 18; p = 0.02). CONCLUSIONS: A diet enriched with EPA, GLA, and anti-oxidants does not improve gas exchange or decrease the incidence of novel organ failures in critically ill septic patients with acute lung injury or ARDS. Patients treated with the EPA-GLA diet stayed in the ICU for less time, but we did not find any differences in infectious complications.


Subject(s)
Acute Lung Injury/physiopathology , Eicosapentaenoic Acid/therapeutic use , Enteral Nutrition , Multiple Organ Failure/prevention & control , Respiratory Distress Syndrome/physiopathology , Sepsis/physiopathology , gamma-Linolenic Acid/therapeutic use , Acute Lung Injury/complications , Acute Lung Injury/therapy , Adult , Aged , Antioxidants/therapeutic use , Cross Infection/epidemiology , Cross Infection/prevention & control , Female , Food, Formulated/analysis , Humans , Incidence , Intensive Care Units , Intention to Treat Analysis , Length of Stay , Male , Middle Aged , Multiple Organ Failure/epidemiology , Multiple Organ Failure/etiology , Respiration, Artificial , Respiratory Distress Syndrome/complications , Respiratory Distress Syndrome/therapy , Sepsis/complications , Sepsis/therapy , Spain/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...